openPR Logo
Press release

Germany In-vitro Diagnostic Services Market Outlook (2018-2024)|key Venddors: BioRad, DexCom, Nova Biomedical, OraSure, Pearl Pathways, Phenomenex, Qiagen, Roche diagnostics, Siemens, Sysmex and Thermofisher.

IVD Services Market

IVD Services Market

Germany market was valued at USD 1.4 billion in 2017. Business growth in the country will be triggered by rising adoption of technologically advanced diagnostic devices. Also, availability of improvised quality diagnostic devices used in blood, urine and other infectious diseases diagnosis coupled with development of reimbursement scenario will stimulate industry growth over the coming years.

With rapid developments in diagnostic testing technology, the global in-vitro diagnostic services market, over the recent years has significantly attracted the interest of investors and major healthcare providers. In fact, according to statistics, diagnosis and clinical testing is used in more than 70% of healthcare decisions and can help provide targeted therapy at much lower costs. The global in-vitro diagnostic services market, in this regard is making a strong headway in the healthcare sector and was worth USD 44 billion in 2017.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/2889

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:

• BioRad
• DexCom
• Nova Biomedical
• OraSure
• Pearl Pathways
• Phenomenex
• Qiagen
• Roche diagnostics
• Siemens
• Sysmex and Thermofisher.

Software in-vitro diagnostic services market to emerge as lucrative investment spot over 2018-2024

Of the two in-vitro diagnostic services, which includes software and testing services, the software segment is gaining immense traction lately. If industry analysts are to be believed, the software diagnostic services are favorably driving the digital transformation in the healthcare industry and are therefore being adopted by several hospitals and point-of-care testing centers. These software services moreover are playing an increasingly significant role in the drug discovery processes via gene sequencing analysis, which is why this segment is expected to be a potential investment ground. Estimates claim the global software in-vitro diagnostic services market to record a CAGR of 4.5% over 2018-2024.

Analyzing the massive growth potential, it is prudent to mention that several prominent industry behemoths are adopting market growth strategies such as M&As, partnerships, JVs, and R&D to expand their business in software diagnostics services. Recently for instance, Roche Diagnostics, partnered with tech-giants such as Microsoft and Cleidon to expand software offering services for providing better healthcare solutions as well as for global business expansion.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2889

How industrial and governmental backing is influencing the commercialization potential of in-vitro diagnostic services market?

Recently, in June 2018, NAMSA, the world’s only Medical Research Organization (MRO) that helps accelerate the development of medical devices through integrated clinical research, laboratory testing, and regulatory consulting services has successfully launched its in-vitro diagnostics development business. This platform, according to reports is expected to provide the global manufacturers a proven resource for commercializing the outcomes delivered via NAMSA’s clinical research services.

These regulatory and clinical services have grabbed the attention of several healthcare providers for a more rapid treatment and diagnosis plans, in turn intensifying in-vitro diagnostic services market demand. Reports cite that the sponsors, who have limited options for IVD-focused CRO (Contract Research Organizations) will benefit majorly from these new service offerings.

In line with such increasing support from the competitive landscape and with the advent of new technologies such as big data analytics, cloud computing, and Internet of Things, the in-vitro diagnostic services market has emerged as a profitable business sphere of the healthcare industry. All in all, the rising prevalence of cancer and other chronic disease and the supportive competitive scenario is further likely to enrich the growth dynamics of global in-vitro diagnostic services industry in the coming years. The global in-vitro diagnostic services market is forecast to cross USD 63 billion by 2024, as compiled by Global Market Insights, Inc.

Related Report:

Diagnostic Ultrasound Market by 2024
https://www.gminsights.com/industry-analysis/diagnostic-ultrasound-market

Trial Management System (CTMS) Market by 2024

https://www.gminsights.com/industry-analysis/clinical-trial-management-system-ctms-market

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: www.gminsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Germany In-vitro Diagnostic Services Market Outlook (2018-2024)|key Venddors: BioRad, DexCom, Nova Biomedical, OraSure, Pearl Pathways, Phenomenex, Qiagen, Roche diagnostics, Siemens, Sysmex and Thermofisher. here

News-ID: 1640720 • Views:

More Releases from Global Market Insights, Inc.

Rare Sugar Market Top 3 Trends, Covid-19 Outbreak, Factors Driving, Threats, Cha …
Rising awareness regarding health & fitness and the subsequent shift in consumer trends towards low-calorie sweeteners will boost rare sugar market share over the forecast spell. Recent years have marked a steady rise in the prevalence of cardiovascular ailments, diabetes, and obesity, among other chronic conditions, which have triggered a massive change in consumer perceptions towards health. This in turn has led to a surge in demand for various functional foods
Global Selenium Yeast Market Industry Assessment, Trends, Competitive Landscape, …
The selenium yeast market is anticipated to register substantial gains on account of rising inclination towards organic additives in animal nutrition, with an aim to improve livestock health and production. Consumers are steadily becoming aware of the downsides associated with using synthetic additives. As a result, they are preferring selenium yeast feed grades over other counterparts to provide balanced nutrition to their livestock. According to Global Market Insights Inc estimates
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key players Eaton, Schneider, Siemens, Hitachi, Powell, Hubbell
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key pl …
Global Power Distribution Component Market Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight. Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/3091 Voltage rating have acted as a standard industry protocol toward the installation of power components reliant on regulatory preference, deployment areas, and the group
Prenatal Vitamin Ingredients Market New Entrants, Risk Factors, Market Expansion …
The rise in the instances of miscarriages on account of poor diet and hygiene will anchor the consumption of prenatal vitamin ingredients. Excessive intake of junk food has resulted in the scarcity of important nutrients in pregnant women that could adversely affect the fetus health and development. Furthermore, prenatal vitamin ingredients possess additional nutritional components that are not so easily sourced from regular food items and products. Prenatal vitamin ingredients can

All 5 Releases


More Releases for IVD

IVD Market 2021 | Detailed Report
The IVD market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The IVD report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period. The IVD research report also provides insights of different regions that are contributing market growth.
Liquid Biopsy IVD Market 2021 | Detailed Report
According to Market Study Report, Liquid Biopsy IVD Market provides a comprehensive analysis of the Liquid Biopsy IVD Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of Liquid Biopsy IVD Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4623688 The report provides a
Infectious Disease IVD Market – Forecast to 2026
The findings reviewed by GME stated that the Global Infectious Disease In-Vitro Diagnostics Market would grow at a CAGR value of 4.6 percent from 2021 to 2026. The increasing geriatric population is the primary driving factor for the infectious disease in-vitro diagnostics market. Besides, the increasing number of infectious diseases, launch of advanced testing kits and beneficial features attributed by IVDs are propelling growth in the market. Browse 159 Market
Asia IVD Market
According to a new report published by Allied Market Research, the Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario. Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1256 The Asia-Pacific IVD market is
LAMEA IVD Market | Business Development Strategies
LAMEA IVD market size was valued at $7,413 million in 2016, and is projected to reach at $10,316 million by 2023, growing at a CAGR of 4.7% from 2017 to 2023. The immunodiagnostics segment accounted for more than two-ninths share of the total market in 2016. Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/4137 In vitro diagnostics (IVD) are medical devices and reagents used for examination of the body samples such as blood, tissue, and
Global IVD Products Market Research Report
This report studies the global IVD Products market status and forecast, categorizes the global IVD Products market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Abbott Laboratories Danaher Corporation Johnson and Johnson Roche Diagnostics Siemens Healthcare BD Biomerieux Bio-Rad Laboratories Ortho Clinical